Sales and earnings (Q3 2022)
- Net revenue
- 483,5 MSEK (+119%)
- Op. EBITDA
- 97,0 MSEK (+70%)
Financial reports
Calendar
- February 16th
- Yearend Report 2022
- March 15th
- Carnegie Nordic Healthcare Seminar 2023 (Stockholm, Sweden)
- March 15th
- Berenberg EU Opportunities Conference (London, UK)
Pressreleases & news
Latest presentations
Presentation of Q3 2022
“The pet industry remains stable despite the chaotic global situation, which unfortunately seems to remain unruly for some time to come. Despite all uncertainty, I remain confident that our industry, and we as a company, will continue to develop since the strong demand in the market continues.” – HĂĄkan Lagerberg, CEO
